Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Effective Hacks To Help You Drive Safely On The Road

Effective Hacks To Help You Drive Safely On The Road

Driving a car is one of the most important things you can do in your life. It’s an essential life skill, and if you don’t know how to drive, it can be really hard to get around. But driving isn’t as simple as turning on the ignition and going- there are plenty of rules that govern what drivers should do at all times. Here are a few tips to stay safe on the road.

1) Maintain a Safe Following Distance

This is one of the most important things to do when driving. When you understand the importance of maintaining a safe following distance at all times you are able to keep your vehicle and its passengers safe, as well as the vehicle in front of you. You should never tailgate or try to pass another car for no reason- it’s not only dangerous but also illegal, so make sure you leave at least two seconds between your car and the one in front of you.

You should always be aware of your surroundings and try to anticipate what could happen next. Drivers cutting you off or swerving can be incredibly dangerous if you don’t see it coming, so make sure you keep an eye on the cars around you and watch out for anything that they

2) Follow the Law

Speeding, texting, and using your phone while driving can lead to serious accidents. If you’re not paying attention to traffic laws, then you’ll put yourself as well as other drivers at risk. Texting while driving is illegal, and using a phone while behind the wheel can get you a fine of more than $100. Texting while driving causes so many deaths each year, so avoid using your phone when driving.

If you have to make a phone call, pull over and concentrate on just that rather than trying to concentrate on your phone and the road.

3) Don’t Drive While Tired

Driving is tiring! If you’re not used to spending hours at a time behind the wheel, then it’s easy to get exhausted. So take regular breaks every hour or so. This can also help you avoid an accident since driving when you’re too tired is very dangerous! Drivers falling asleep behind the wheel cause about 100,000 accidents per year in the US.

Make sure that you look for rest stops and that you calculate them into your route. Another option is to have a co-pilot. Have someone take over when you are too tired to drive. Take turns so that the long drive is not as exhausting on both of you. Don’t think that drinking copious amounts of coffee will be enough to keep you going.

4) Don’t Drive While Intoxicated:

One of the biggest causes of accidents is people drinking too much and then getting behind the wheel. Studies have shown that drunk drivers are responsible for about 10,000 deaths each year in the US, so it’s really important not to drink or and drive. If you do want to drink, make sure you have a designated driver or organized taxi service. Roads are very dangerous when there’s any alcohol involved. Remember that driving after just two drinks is twice as likely to cause an accident than when no alcohol was involved. Also, do not drink when you are on strong medication. You might be able to drive perfectly safely after a drink, but when alcohol and medication are combined it can lead to drowsiness, or extreme intoxication very quickly.

Do not take drugs and drive. When you add in the effects of any drug you could lose a lot of concentration very quickly. This is a dangerous mixture and can put so many other people in danger.

5) Maintain your Vehicle Regularly

You’re more likely to have an accident if you don’t take care of your car properly. Check for fluid levels each time before starting out on a long trip- brake fluid needs changing every two years or so, while coolant should be replaced every 5-6 years. Keeping your car clean makes it easier for you to spot any possible problems, and if you keep up on regular maintenance, it should last much longer without having to be replaced (and that means saving money in the long run). Also, make sure that your tires are properly inflated and brakes work correctly before getting on the road.

Driving can be challenging, but it is important to stay alert and follow traffic laws. Doing so will help you avoid accidents or other dangerous incidents that could lead to serious consequences. For example, texting while driving can get you a $100 fine in some places (or more). You should also make sure your car is maintained regularly with regular breaks taken every hour or so. When it comes down to it, the most important thing is to drive responsibly.

Smarter Health Partners with Prudential to Expand Health Offerings on Pulse by Prudential

Smarter Health Partners with Prudential to Expand Health Offerings on Pulse by Prudential

Smarter Health, a Singapore-based healthcare technology company, announced  its partnership with Prudential plc. With this partnership, users of the Pulse by Prudential app will be able to access a directory of specialist doctors and health screening services, and make appointments online. To begin with, Smarter Health’s services will be made available to employees of Prudential’s corporate customers in Singapore and the Philippines through Business@Pulse.

Smarter Health operates a secure and privacy-preserving platform to facilitate interactions between insurers and healthcare service providers in the Southeast Asia region. Led by seasoned senior executives across the full spectrum of the healthcare ecosystem, the team brings together deep domain expertise in healthcare operations and medical insurance.

Pulse is an artificial intelligence (AI) – powered mobile app designed to bring holistic health and wealth services to Prudential’s customers and communities in its markets across Asia and Africa. Business@Pulse is a platform within Pulse that supports small and medium enterprises (SMEs) by broadening and simplifying access to insurance and employee benefits.

Mr Dennis Ng, Chief Executive Officer of Business@Pulse, said that as more people adopt digital tools in their everyday lives, Prudential is providing a platform that allows people to access integrated health and wealth services more conveniently.

“An Asia-wide survey[1] that Prudential conducted showed that people are relying more on technology to improve their personal health and wellbeing. This trend has accelerated since the pandemic. We are pleased to partner with Smarter Health to make healthcare services more accessible to our customers,” said Mr Ng.

“Smarter Health is delighted to be partnering with Prudential in their mission to help people achieve better health outcomes with technology,” said Mr Liaw Yit Ming, Chief Executive Officer at Smarter Health. “We will constantly review and grow our network of healthcare service providers so that Pulse users can be assured of continued access to the right care all in the palm of their hands.”

Pulse is part of Prudential’s strategy to provide affordable and accessible healthcare and make financial planning simpler for everyone across Asia and Africa. Launched in Malaysia in August 2019, Pulse is now available in 19 markets and 11 languages in Asia and Africa, and has been downloaded more than 31 million times.

About Smarter Health

Smarter Health provides a trusted infrastructure for data exchange between key stakeholders of the healthcare ecosystem. Our “SIMPLIFY, STANDARDISE and SYSTEMISE” approach supports the delivery and payment for healthcare services in an efficient and effective manner. We believe that healthcare should be ACCESSIBLE, AFFORDABLE and ACCOUNTABLE. The Smarter Health team consists of experienced senior executives from established healthcare and insurance institutions in Asia.

About Prudential plc

Prudential plc provides life and health insurance and asset management, with a focus on Asia and Africa. The business helps people get the most out of life, by making healthcare affordable and accessible and by promoting financial inclusion. Prudential protects people’s wealth, helps them grow their assets, and empowers them to save for their goals. The business has more than 17 million life customers in Asia and Africa and is listed on stock exchanges in London, Hong Kong, Singapore and New York.

Prudential plc is not affiliated in any manner with Prudential Financial, Inc., a company whose principal place of business is in the United States of America or with The Prudential Assurance Company Limited, a subsidiary of M&G plc, a company incorporated in the United Kingdom

Healthcare leaders come together for the 44 th World Hospital Congress

Healthcare leaders come together for the 44 th World Hospital Congress

The 44thWorld Hospital Congress (WHC)starts at the Fira Montjuïc conference centre, Barcelona (Spain), a year later than originally planned due to the Covid-19 pandemic.

For the first time, the WHC is fully hybrid, facilitating the participation of more than 1,200 delegatesfrom over 70 countries in the entire programme whether they attend in-person and virtually. The WHC is the premier event in the International Hospital Federation’s (IHF) calendar and their organizing partner and host for the 44th WHC is La Unió Catalana d’Hospitals (UCH).

For four days, leaders and decision-makers in the healthcare community willshare knowledge and good practices, exchange new ideas and innovations, and network with other senior executives.The 44th WHC features:

  • 70+ plenary and parallel sessions
  • 300+ speakers
  • 200+ posters
  • 60+ paper presentations
  • 60+ lightning talk presentations
  • 30+ exhibitors

The theme for this 44thWHC is “People on board: Transforming healthcare by blending agility, responsiveness, and resilience”. Dr Enric Mangas, President of the UCH and Chair of the Organizing Committee, underlined the importance of knowledge exchange between hospital leaders as they focus their efforts on building back from the pandemic:

“In Barcelona we have an outstanding opportunity to move forward together in improving healthcare. And we’ll do so with a firm commitment to people.

We propose a journey through all the opportunities offered by technology and knowledge, with an incursion in humanism, to ensure there is health and social care of value for everyone and anyone who needs it. And put in place learnings on how we can transform our healthcare services to be agile, responsive and resilient to meet people’s needs.”

In a packed, quality programme the highlights include:

  • Opening Ceremony (9:00 CET, 9 November):Dr Hans Kluge, Regional Director for Europe of the World Health Organization, will provide the keynote address.
  • Plenary 1 (11:00 CET, 9 November):Speakersincluding public health leaders and hospital CEOs in Europe and North America will exchange ideas on getting ready for the next global pandemic.
  • Plenary 2 (13:30 CET, 9 November): Key stakeholders from industry, governments and global public health will discuss the lessons to learn fromaccelerating research, development and distribution of the COVID-19 vaccine.
  • Plenary 3 (9:00 CET, 10 November): Leaders in nursing will share examples of their critical contribution to transforming healthcare during a worldwide pandemic.
  • Plenary 4 (13:30 CET, 10 November): A European-focused session, exploring ways to adopt, implement and scale up the organizational and technological innovations to come from the pandemic.
  • IHF Awards 2021 (18:00 CET, 10 November):The winners in each of six prestigious categories will be announced at a special ceremony.
  • Plenary 5 (08:30 CET, 11 November): Speakers from healthcare and industry will demonstrate the potential of technology to better humanize healthcare and deliver a more personable and dedicated patient experience.
  • Closing Plenary and Ceremony (14:00 CET, 11 November): Esteemed guests from WHO, Catalonia and Dubai will provide keynote addresses and formally hand over the Congress to Dubai Health Authority, the host in 2022.
  • Site visits:Tours ofsix of the most advanced hospitals and health institutions in Barcelona.

Deborah Bowen, FACHE, CAE, is president and Chief Executive Officer of the American College of Healthcare Executives Federation and will commence her role as President of the International Hospital Federation at the Closing Ceremony. Stressing the importance of the WHC as an opportunity to connect with peers, she said:

“The World Hospital Congress gives us the chance to reflect on our accomplishments and progress, learn from one another and better navigate what lies ahead.”

The 45th World Hospital Congress will take place in Dubai (UAE) on 9–11 November 2022.

About the World Hospital Congress (WHC):

The WHC is a unique global forum connecting leaders and decision-makers of hospitals, health services, and healthcare organizations to share knowledge and good practices, exchange new ideas and innovations, and network with other senior executives from across the international healthcare community. In 2021 it was held on 8–11 November in Barcelona (Spain). The 45th edition will take place in Dubai(UAE) on 9–11 November 2022.

About the IHF Awards:

The IHF Awards were launched in 2015 and are recognized around the world as the premier awards programme to honour hospitals and healthcare organizations. Past winners have benefited from the IHF Awards with global recognition that inspires their teams, and the global healthcare community, to strengthen their commitment to the causes highlighted in each Awards category, as well as by earning generous donations to further support their projects. The Awards were first presented in 2015 in Chicago (USA) at the 39th WHC. https://worldhospitalcongress.org/awards/

About the International Hospital Federation (IHF):

Established in 1929, the IHF is a global not-for-profit, non-governmental membership organization.Headquartered in Geneva, Switzerland, the IHF is the global voice of hospitals and health systems. The IHF provides its members with a platform for knowledge exchange and networking with different actors in the health sector, to improve the standard, quality, and level of service delivery.

About La UnióCatalana d’Hospitals (UCH):

La Unió Catalana d’Hospitals has been an association of health and social organizations for more than 45 years.La Unió is a reference for the uniqueness of the Catalan health and social model in terms of plurality, diversity, and territoriality. It brings together more than 114 entities, with more than 750 health and social care devices and more than 65,000 professionals, with a presence throughout Catalonia and in all lines of care: primary, hospitals, social health, mental health, rehabilitation, the elderly, the disabled.

It is an association of organizations of people who work for people, who from the respect of diversity share the social commitment for the improvement of health and wellbeing, contributing in public policies through the professionalized ethical management, innovation and evaluation of results aimed at continuous improvement.

Cherokee Health Systems Partners with Noteworth to Boost Provider-patient Engagement, Value-based Care

Health Symptoms That You Shouldn't Ignore

Noteworth, a virtual care delivery platform that uses remote patient monitoring, artificial intelligence and powerful data analysis tools to improve patient outcomes, announced its partnership with Cherokee Health Systems (CHS). CHS is a Federally Qualified Health Center (FQHC) based in Tennessee that serves 75,000 patients annually in its 23 facilities and will utilize Noteworth’s digital health services to accelerate proactive interventions, boost clinical outcomes and patient satisfaction, and reduce care costs.

“Access to care for many patients of the U.S. population remains a challenge, especially in rural areas which makes the adoption of innovative digital health solutions so critical for FQHC’s like Cherokee,” said CHS’ Chief Information Officer Andy Rhea. “We are thrilled to partner with Noteworth and implement their platform to help us continue on our value-based care journey to deliver the best care possible.”

Cherokee Health Systems plans to deploy Noteworth’s full suite of products to help it address disease, finesse its telehealth delivery, and expand its digital front door. Leaders expect significant return on investment from the affordable platform, including new reimbursement streams, expanded care access, patient engagement and brand differentiation.

Noteworth is the first end-to-end digital health platform serving the entire ambulatory care journey, known for improving patient outcomes and reducing costs. Unlike other incongruent solutions, Noteworth offers a turnkey approach to digital health including:

  • Telemedicine and care coordination, including pediatric and adult medicine programs.
  • Condition management, including diabetes and transitional care.
  • Remote patient monitoring, for rising-risk, high-risk, chronically ill and other patients.
  • Patient engagement, such as education and wellness programs.
  • Home health, including aging-in place, hospice, and home infusion solutions; and
  • Behavioral health programs, including solutions for ADHD, anxiety, and depression management.

Noteworth, which can be used as a standalone solution or integrated with an existing EMR, reduces the administrative burden on caregivers by streamlining their workflows. Noteworth’s all-encompassing solution is designed to help providers in both fee-for-service and value-based care organizations simplify patient assessments, records, and other administrative tasks. This keeps clinicians centered on one platform and saves them time.

“Virtual care is the future of healthcare, and our delivery platform encompasses all the digital solutions health systems need to do their job effectively, one that focuses on patient care and scalability,” said Raymie McFarland, Head of Sales, Noteworth. “Studies show that effective digital healthcare solutions help providers and patients save money. It also helps providers deliver their best possible care, which is critical as the industry transitions from volume to value.”

“Although health systems are seeing more in-person visits, digital healthcare platforms remain essential because they expand access, improve outcomes and enhance the patient experience,” said CHS’ Chief Operating Officer Suzanne Bailey, M.D. “We welcome Noteworth’s help in decreasing the administrative burden on our clinicians, enabling our providers to put 100 percent of their focus on patients.”

As the largest health center in the state, implementing innovative ways to improve the care system and reach new patients remains an institutional priority at Cherokee Health Systems. The health center provides primary care, behavioral health services, pharmacy, and dental services to patients across 23 clinics. Through virtual care, patients, especially chronically ill populations, who cannot make it to the doctor’s office are a just few clicks away from a visit, and nurses have more time to see admitted patients.

“At Cherokee, we aim to meet patients where they are. As virtual health gains momentum, it’s becoming a core component in helping patients improve or maintain their well-being,” said CHS’ Chief Clinical Officer Parinda Khatri, M.D. “We strive to remain on the cutting-edge side of technology and adapt new ways to provide high-quality health services to patients across the state.”

Noteworth’s digital health solutions will also help CHS on cost savings up-front and in the long-run as the healthcare industry transitions from fee-for-service to value-based care models, opening CHS up to new reimbursement streams.

About Noteworth

Noteworth provides a comprehensive and scalable virtual care delivery platform that enables continuous, high-touch patient care and engagement across multiple specialties and chronic conditions. The platform combines patient engagement and behavioral interventions with built-in alerts to increase touchpoints and pass key information to clinical staff to facilitate proactive interventions, improve patient outcomes, and decrease care costs. Noteworth is a privately held company headquartered in Jersey City, New Jersey.

About Cherokee Health Systems

Since 1960, CHS has been committed to ensuring Tennesseans get access to effective, high-quality care. CHS is a Federally Qualified Health Center that serves 75,000 people annually. We offer a wide array of comprehensive health services, including primary care, behavioral health, dental, and pharmacy. All of our services are available to children, adults, and seniors on an ability to pay basis. CHS is a TennCare (Medicaid) and Medicare provider. In addition, CHS accepts commercial insurance for payment.

Essence SmartCare to Showcase Advanced Connected Health Solutions at MEDICA 2021

Essence SmartCare to Showcase Advanced Connected Health Solutions at MEDICA 2021

Essence SmartCare announced it will showcase two advanced IoT-based health and safety products at the upcoming MEDICA Forum, demonstrating the company’s leadership in comprehensive remote patient monitoring (RPM) and advanced fall detection.

VitalOn is a breakthrough platform in the telehealth market unifying telecare, wellness and remote patient monitoring capabilities into a single, continuously connected platform. The award-winning solution is always on, providing continuous monitoring and chronic conditions management for a wide range of healthcare needs, both in the home and on-the-go. It continually monitors health factors and vital signs, alerting caregivers or clinicians in cases of abnormal activity. Its superb user experience addresses a range of aging-related issues and chronic conditions – including diabetes, hypertension and congestive heart failure – without having to rely on smartphone or tablet apps.

MDsense is the first multi-dimensional fall detection solution for elderly and vulnerable populations. Unlike alternative solutions, which rely on wearable devices and panic buttons, the system utilizes advanced algorithms to immediately detect a fallen individual. The non-wearable, wireless, battery-powered solution provides round-the-clock monitoring and enables caregivers to respond to events faster by eliminating the risk of missed falls or false alerts. Key features include an immediate alarm, automatic real-time person recognition, and the ability to differentiate between humans and pets. Employing wall-mounted smart sensors rather than video cameras, the system works even in total darkness while ensuring total privacy. MDsense is part of the company’s Care@Home platform that allows seniors to live independent and safe lives in their homes.

“Essence remains committed to increasing the efficiency of advanced health and care services, providing people with peace of mind by enabling them to live healthier and happier lives,” said Barak Katz, General Manager for Essence SmartCare. “The VitalOn and MDsense solutions demonstrate our leadership in remote care by introducing medical grade innovations that help our users to remain free and independent, safe in the knowledge that their health and welfare needs are taken care of.”

“We are continually working to update and optimize our technology offerings, so that they address the evolving needs of our users,” said Dr. Haim Amir, CEO and Founder of Essence Group. “Both VitalOn and MDsense exemplify this, and our larger mission to harness cutting-edge technology to introduce solutions that demonstrably improve people’s lives.”

Demonstrations of Essence SmartCare’s range of connected homecare solutions will be conducted in Hall 12, Booth A26 at MEDICA from November 15-18, in Dusseldorf.

 

Sydney LHD extends use of Miya Precision remote patient monitoring platform

How touchless patient monitoring is defining future of healthcare landscape

The Sydney Local Health District will continue using a remote patient monitoring platform by ASX-listed healthcare IT company Alcidion after extending their contract.

In July last year, Alcidion signed an initial 12-month contract with the LHD to deploy its Miya Precision system to support the virtual care delivery of Sydney’s RPA Virtual Hospital (rpavirtual) for COVID-19 patients in home isolation.

With around 12,000 staff, Sydney LHD is serving over 700,000 people across central and inner-west Sydney. It oversees five hospitals, including the Royal Prince Alfred and Concord Hospitals, and a range of in-hospital and community-based support services.

Miya Precision has been supporting the virtual hospital’s doctors with a clinical monitoring dashboard that consolidates information, supporting their delivery of remote patient care. The platform is also helping to reduce hospitalisations and improve recovery outcomes.

The expanded implementation, according to a press statement, will use Miya Precision to remotely monitor the conditions of patients with acute diverticulitis. It will include bi-directional integration with Sydney LHD’s Cerner EMR.

Moreover, both organisations will collaborate to deploy the Miya Care mobile patient app, which will allow rpavirtual to actively monitor care progress and enhance its engagement with patients. The app will integrate data from patient monitoring devices and patient wearable technology.

In September, healthcare IT firms Royal Philips and Teladoc Health announced their partnership to offer virtual care solutions in Australia and New Zealand. Combining their virtual care offerings, the companies will deliver to hospitals and health systems a scalable end-to-end virtual care service that allows them to conduct remote patient monitoring across health facilities with limited clinical resources.

Meanwhile, the University of South Australia has recently developed an AI-enabled platform to remotely monitor the vital signs of premature babies and detect their faces while lying in hospital beds.

“We are very excited to build on our initial implementation of Miya Precision with Sydney [LHD] through this project that highlights the flexibility and scalability of our platform as a key enabler of new and innovative models of care,” said Alcidion Managing Director Kate Quirke.

“The opportunity to extend our technology to provide improved information and communication options for the patient in the home will significantly improve the patient experience and contribute to better outcomes,” she added.

QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech

QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech

QuantuMDx Group Limited announces it has secured a £15 million equity investment from Vita Spring IVD Fund, L.P., a Hong Kong-based venture capital firm focused on early and growth stage medical companies with disruptive technologies and global market potential. Proceeds from the financing will be used to further the development and evolve the Q-POC™ platform to increase its functionality. The Company also plans to expand the menu of tests for Q-POC™ adding a multiplex respiratory panel, sexually transmitted infections (STIs), and HPV, amongst others, to the current SARS-CoV-2 assay.

Jonathan O’Halloran, Chief Executive, QuantuMDx, said: “I am very pleased to announce this equity investment today which will enable us to further evolve the Q-POC™ platform, making our system one of the most innovative, high multiplexing, molecular point of care devices in the market. Vita Spring shares our mission of developing accurate and efficient solutions to identify pathogens and diagnose diseases and so we are delighted they have chosen to invest in QuantuMDx. We are also looking forward to our close future relationship with Sansure and believe they will be an excellent partner for QuantuMDx in China as we look to increase our global footprint in Chinese and adjacent markets.”

James Yan, Partner, from Vita Spring said: “We are delighted to invest in QuantuMDx, which is equipped with world class technologies to address acute and ever-growing point of care testing needs globally. We are also fortunate to have the opportunity to bridge the innovative technology and platform into the China market and look forward to working with Jonathan and his team to fully realize the potential of QuantuMDx as it enters into the commercial stage.”

Dr Keya Zhang, Head of Corporate Strategy from Sansure, said: “We are very impressed by the QuantuMDx team and by the capabilities of the Q-POC™ platform. QuantuMDx’s first test, a SARS-CoV-2 detection assay on its Q-POC™ device, is already validated and on the market and it is clear there is a great deal of potential in other indications beyond that. We only partner with innovative, world-class businesses, and technology with proven advanced levels of performance, and so QuantuMDx is a natural fit for Sansure and its future expansion ambitions.”

About QuantuMDx:

QuantuMDx is a company passionate about empowering the world to control disease and reduce suffering. QuantuMDx tackles real-world diagnostic problems by delivering molecular point of care solutions for anyone, anywhere. QuantuMDx has operations and strategic partnerships in the United States, Asia, Australasia, Europe, and Africa – keeping it at the forefront of molecular diagnostics.

Q-POC™ is a rapid, simple to use, portable, sample to answer PCR device and has been designed for use in a wide range of settings, such as hospitals, clinics, pharmacies, and workplace testing providing accurate PCR results at the point of need. Q-POC™ and its first test, a SARS-CoV-2 detection assay, are CE-IVD marked under the In Vitro Diagnostics Directive (98/79/EC), enabling use within Europe. For more information about QuantuMDx and Q-POC™, its rapid PCR point of care system, go to: www.quantumdx.com
About Vita Spring:

Vita Spring is a Hong Kong-based venture capital fund which focuses on discovering and empowering early and growth stage medical companies with disruptive technologies and significant global market potential. Vita Spring’s management team and its strategic partners have been involved in the investment and operation of the healthcare industry for years. Vita Spring has established a global network, with a forward looking vision. With the combination of strong scientific genes and skilled capital operations, Vita Spring aims to build a sustainable “industry + capital” ecosystem.

About Sansure:

Sansure is an in-vitro diagnostic solution provider founded in Changsha, Hunan province, China in 2008, with over 1,500 employees and a broad product portfolio. It is engaged in research and development, production and sales of diagnostic reagents and instruments. Sansure listed on the Shanghai Stock Exchange’s STAR Market on 28 August 2020 raising RMB2.0 billion (c.US$300 million), and as of 27 October 2021 had a market capitalization of approximately RMB21.6 billion (c.US$3.4 billion). It was also one of the first molecular diagnostics companies to have its SARS-CoV-2 test kits approved in China, which are now sold to over 160 countries. Sansure’s founder and Chairman, Dr Li Zhong Dai, is a scientific advisor to Vita Spring.

 

Philips to expand its cardiac diagnostics and monitoring portfolio with the acquisition of Cardiologs

Philips to expand its cardiac diagnostics and monitoring portfolio with the acquisition of Cardiologs

Royal Philips, a global leader in health technology, announced that it has signed an agreement to acquire Cardiologs, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology. Cardiologs will further strengthen Philips’ cardiac monitoring and diagnostics offering with innovative software technology, electrocardiogram (ECG) analysis and reporting services. The transaction, which is subject to customary closing conditions, is expected to be completed in the coming months. Financial details of the transaction were not disclosed.

The acquisition of Cardiologs is a strong fit with Philips’ existing portfolio of cardiac care solutions. This includes real-time patient monitoring, therapeutic devices, telehealth and informatics for the hospital, as well as ambulatory cardiac diagnostics and monitoring solutions, that were added through the recent acquisition of BioTelemetry, Inc.

Cardiologs will complement this offering with a vendor-neutral heart disorder screener and ECG analysis applications, based on machine learning algorithms. Developed in partnership with leading physicians, Cardiologs’ technology accelerates diagnostic reporting, decreases the occurrence of reporting errors and streamlines clinician workflow and patient care, empowering clinicians to deliver expert cardiac care faster and more efficiently. CE-marked and FDA cleared for detection of cardiac arrhythmias, Cardiologs’ technology is built on a growing database of more than 20 million ECG recordings and supported by a number of clinical publications.

Offering superb clinical insights, as well as automated clinical reporting, Cardiologs’ medical-grade AI technology and data scientists will be a strong addition to our growing portfolio of cardiac solutions for hospital and ambulatory settings.

Cardiologs was founded in 2014 and is headquartered in Paris, France. Its approximately 70 employees, largely comprising software engineers and data scientists with expertise in AI and deep learning algorithms, will join Philips and will expand the company’s continued AI-focused innovation activities together with the company’s R&D lab in Paris. Philips has a strong presence in France, consisting of research and development activities, as well as sales, marketing and distribution at multiple sites.

KORU Medical Announces Collaboration With Gilero to Accelerate Innovation

KORU Medical Announces Collaboration With Gilero to Accelerate Innovation

Repro Med Systems, Inc. dba KORU Medical Systems, a leading medical technology company focused on the development, manufacturing and commercialization of innovative and easy-to-use home infusion solutions announced its collaboration with Gilero, a medical device design and manufacturing company. Gilero offers unparalleled engineering and manufacturing solutions and has been a trusted partner for medical and drug delivery device companies for 20 years. The collaboration is part of KORU Medical’s strategic focus on innovation as the Company expands and evolves its at-home infusion products and portfolio.

“As KORU Medical seeks to advance our leadership position in large volume subcutaneous infusion technology, we are increasing our innovation efforts to meet the needs of patients, providers, biopharmaceutical companies, and regulators. This collaboration with Gilero, a company we chose due to their substantial expertise in infusion and combination drug/device platforms, will accelerate our product and service innovation efforts,” said Linda Tharby, KORU Medical’s Chief Executive Officer. “We will continue to focus our product development efforts on increasing comfort and convenience in the patient infusion process as we look to support the needs of a growing trend to home infusion.”

“Gilero is pleased to have been selected as the preferred contract engineering firm for KORU Medical [Systems],” said Ted Mosler, CEO and Founder of Gilero. “Our broad service offerings, including in-house human factors, validation testing, and concept design engineering, coupled with our expertise related to complex drug delivery systems, allow us to provide a turnkey solution for KORU Medical as they continue to expand their line of home infusion products. The team at Gilero is looking forward to working closely with KORU Medical.”

Northwell, Aegis Ventures team up on AI enterprise to address healthcare quality and cost

Northwell Health New York’s largest health care provider, and Aegis Ventures, a New York-based startup studio,  announced they are forming a joint venture (JV) that will ideate, launch, and scale AI-driven companies to address health care’s most challenging quality, equity, and cost problems. The JV will assemble leading medical, technology, and business resources to create a first-of-its-kind company creation platform for health care innovation. Aegis Ventures intends to invest at least $100 million of seed-stage funds through the platform to catalyze a significant multiple of that amount from the venture capital and investment community.

The JV will work with stakeholders across the Northwell system to create new patient care solutions through collaboration with frontline clinicians, working side-by-side from ideation to implementation, to develop innovations that use AI to predict, diagnose, and manage health conditions.

The parties have already started work on solutions related to improving maternal health outcomes and chronic disease prediction. Alongside this disease focus, the JV will use AI to identify and eliminate operational inefficiencies in health care delivery. All technologies and tools will be identified, developed, and validated within the secure Northwell Health environment to maximize data integrity and privacy. Ultimately, the aim of the JV will be to accelerate the speed with which new lifesaving AI solutions reach the patient’s bedside.

“New York was at the epicenter of the COVID-19 crisis, and today’s announcement places it at the epicenter of innovation that will tackle health care’s most pressing problems,” said Michael Dowling, president and CEO of Northwell Health. “This joint venture will leverage data from Northwell’s patient population, one of the most diverse in the world, along with Northwell’s intellectual capital in AI technology. Working together, Northwell and Aegis will create companies that bring higher quality, lower-cost health care to those who need it most.”

Northwell has a track record of success in AI research, including the development of a landmark algorithm that predicts patients’ overnight stability to reduce the need to wake them for vital sign checks. Developed using 26 million measurements from 2.3 million patient visits, the algorithm helps reduce nighttime disturbances to speed patients’ recovery and discharge. In addition, Northwell serves one of the most diverse patient populations in the United States. Caring for more than 2 million people annually across 23 hospitals and hundreds of other facilities provides the health system’s clinicians and researchers with a unique vantage point into the health and wellbeing of traditionally underserved communities. This perspective will be a key aspect of the Northwell-Aegis JV, which will prioritize innovation to reduce racial and socioeconomic biases that drive health inequities and have impaired existing AI solutions.
Complementary AI goals

“Aegis’ experience in commercialization and Northwell’s experience in clinical care complement each other perfectly,” said Aegis Ventures Chairman Bill Schoenfeld. “Our joint platform will bring together the medical, technological, and investment talent to launch new companies that address healthcare’s most pressing challenges.”

In addition to linking clinicians, researchers, patients, and other health care stakeholders, the Northwell-Aegis JV platform team will include exceptional entrepreneurs, data scientists, engineers, and industry leaders with the commercial acumen needed to bring these innovations to the patient’s bedside. From day one, the JV will prioritize the needs of patients and clinicians, and develop best practices in ideation, research, and company creation to significantly accelerate the pace of AI development and adoption. This represents a new, more targeted approach to the way in which venture capitalists and health care systems can work together to solve major health care challenges.

“Our mission is to catalyze a new Moore’s Law in healthcare where, as we continually improve access, we continually reduce cost,” said Tom Manning, Chairman of the Northwell-Aegis JV and former Chairman & CEO of Dun & Bradstreet, the leading global provider of corporate information and data analytics. “This new effort promises to transform the model for innovation in health care and improve outcomes for everyone, but particularly for people who may be lost in the shuffle and most need our help.”

Through the launch of the JV, Northwell and Aegis are committed to building an exceptional team that will embrace this unique opportunity to create impact. Learn more about the JV or register your interest in joining the team that will further these unique opportunities.

1...384385386...1,127Page 385 of 1,127

About us

Hospital & healthcare Management is a leading B2B arena designed for the healthcare sector, it allow members to reach both ends of the healthcare facility procurement chain. . . Read More

Subscribe us

System

Resources

Archive Links

Subscribe

Copyright © 2008 - 2026 Hospital & Healthcare Management. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »